TY - JOUR T1 - PWE-172 A National Biofeedback Practitioners Service Evaluation JF - Gut JO - Gut SP - A201 LP - A201 DO - 10.1136/gutjnl-2014-307263.432 VL - 63 IS - Suppl 1 AU - KJ Etherson AU - E Horrocks AU - M Scott AU - CH Knowles AU - Y Yiannakou Y1 - 2014/06/01 UR - http://gut.bmj.com/content/63/Suppl_1/A201.1.abstract N2 - Introduction Within the UK, there is anecdotal evidence of disparity in the training, practice, supervision, and perception of efficacy amongst practitioners of biofeedback therapy for chronic constipation. Methods Between October 2012 and October 2013, a prospective service evaluation was distributed to biofeedback practitioners in the UK through academic conferences or by invitation to complete an online assessment form. Results 76 practitioners responded, consisting of nurses (47%), physiotherapists (35%), physiologists (12%) and others (7%). Only 45% described ‘biofeedback’ consistent with an accepted definition. 86% use equipment to provide sensory feedback. Methods of biofeedback varied: balloon catheter (54%), brace pump technique (78%), urge resistance (83%), irrigation (16%), and relaxation (12%). Only 65% of practitioners had attended formal training courses, and 52% considered themselves to be self-tau, UKght. 36% receive formal supervision and only 38% of those by a senior. Regular audit of outcomes is undertaken by 67%. UK-wide perception of treatment response for chronic constipation is markedly variable (mean response = 57% [IQR: 50–75%, SD 23%]); there were no differences in perception of treatment response between nurses or physiotherapists. Practitioners’ free responses demonstrated strong positive themes of a holistic approach and an overall perception of effectiveness. Negative themes included service restrictions. Abstract PWE-172 Figure 1 Conclusion There is marked variation in practice, training, and supervision of biofeedback therapists throughout the UK. Perceptions of efficacy vary greatly. Development of training and supervision standards is a priority as well as consensus to standardise therapy. Disclosure of Interest None Declared. ER -